Insomnia can disrupt daily life by causing irritability, exhaustion, tiredness, and difficulty staying focused. This affliction is also believed to be a risk factor for other diseases, including obesity, hypertension, diabetes, and cardiovascular disease.
Chronic, or recurrent, insomnia is a widespread condition affecting nearly 10-15% of the global population.
Even acute, or short-lived, insomnia, if left untreated, can develop into chronic insomnia and becomes more challenging to treat.
How to deal with insomnia through the appropriate treatment depends on whether it presents concurrently with other diseases.
A strong relationship is known to exist between insomnia and other mental disorders such as depression, anxiety, various psychological disorders, and substance abuse. In the case of concurrent, or secondary insomnia, treatment options may include prescription drugs such as antidepressants or cognitive behavioral therapy targeting one or both disorders. In contrast, primary insomnia – which does not present with other disorders – is specifically targeted during treatment.
A physician assessing how to deal with insomnia may not recommend treatment for acute insomnia. If the presenting insomnia is mild, the physician may recommend changes to one’s sleep habits.
A third option, which is non-invasive as well as scientifically verified, is neurofeedback therapy to address the symptoms associated with insomnia.
Insomnia can create tension on the nervous system, which then results in some of its many symptoms. BrainCore Therapy relies on neurofeedback – or qEEG biofeedback – to effectively address the brainwave dysregulation found in insomnia, as well as other conditions, with a team of reliable and knowledgeable doctors.
Content courtesy of www.aboutneurofeedback.com.
For more information about research on insomnia and neurofeedback, as well as articles, videos, news clips, and book recommendations, please visit the BrainCore Resources page.